Unique ID issued by UMIN | UMIN000023904 |
---|---|
Receipt number | R000027529 |
Scientific Title | A clinical trial of the external preparations on the keratosis patients. |
Date of disclosure of the study information | 2016/09/27 |
Last modified on | 2017/03/06 11:27:36 |
A clinical trial of the external preparations on the keratosis patients.
A clinical trial of the external preparations on the keratosis patients.
A clinical trial of the external preparations on the keratosis patients.
A clinical trial of the external preparations on the keratosis patients.
Japan |
Keratosis
Dermatology | Adult |
Others
NO
To confirm the clinical efficacy and safety of topical external preparations in the treatment of keratosis.
Safety,Efficacy
Efficacy (keratosis and wrinkle grade) and safety assessment of the test samples by the principal investigator or the sub-investigator before and after the four- and the eight-week application.
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Active
2
Treatment
Medicine |
Apply topical prescribed drug for keratosis twice a day for 8 weeks.
Apply topical comparator product twice a day for 8 weeks.
50 | years-old | <= |
69 | years-old | >= |
Female
1) Japanese.
2) The persons who have dry and/or stiff feeling in the facial skin.
3) The persons who can peel off the goods for double eyelid at the time.
4) The persons who do not mind the base material and/or solvents adhere to the eyelashes at the time of the replica picking (, if the patients with eyelash extensions).
5) The persons with tending to stay indoors and who have no plans to go out (travel, business trip, etc) during the test period.
6) The persons who agree with the joining this study based on the consent by the document.
7) Patients with some keratosis on the test site (Corner of the eye and lower eyelid) that was diagnosed by the principal investigator or the sub-investigator.
8) Patients who do not have scratches, warts, pimples or burns on the test site, which might have negative impact in the evaluation and measurement.
9) Patients who have wrinkles on the test site, which belongs to the grade 3 to 6 ("Evaluation guidelines for the new efficacy acquisition of Anti-wrinkle product" published by Japanese cosmetic science society).
10) Patients who have the wrinkles belonging to similar grade in the left and right on the test site.
1) Patients with history of allergy to cosmetics.
2) Patients who are receiving hormone replacement therapy.
3) Patients with experience of cosmetic medicine that might have negative impact on the test site.
4) Patients who are being treated with dermatology.
5) Pregnant or lactating patients. Patients with suspicion of pregnancy.
6) Patients who are participating in other clinical trials
7) Patients deemed inappropriate to participate in this study by the principal investigator or the sub-investigators.
30
1st name | |
Middle name | |
Last name | Takashi Koikeda |
Shiba Palace Clinic
Chief of Clinic
DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN
03-5408-1599
jimukyoku@mail.souken-r.com
1st name | |
Middle name | |
Last name | Miwa Kaneko |
SOUKEN CO., LTD
Secretariat
DaiwaA Hamamatsucho Bldg. 5F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN
03-5408-1557
m_kaneko@mail.souken-r.com
Shiba Palace Clinic
Kao Corporation
Profit organization
NO
芝パレスクリニック(東京都)
2016 | Year | 09 | Month | 27 | Day |
Unpublished
Completed
2016 | Year | 08 | Month | 25 | Day |
2016 | Year | 09 | Month | 28 | Day |
2016 | Year | 09 | Month | 02 | Day |
2017 | Year | 03 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027529